• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ATRIUM MEDICAL CORPORATION FLIXENE VASCULAR GRAFTS; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ATRIUM MEDICAL CORPORATION FLIXENE VASCULAR GRAFTS; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER Back to Search Results
Device Problem Use of Device Problem (1670)
Patient Problem Pain (1994)
Event Type  malfunction  
Manufacturer Narrative
On completion of the investigation a follow up report will be submitted.
 
Event Description
An inquiry was made by the nephrologist inquiring about the access technique to cannulate the flixene vascular grafts in patients that experience pain.
 
Manufacturer Narrative
There was no device returned and no product part number or lot number provided therefore a device history record review could not be performed.An inquiry was made by an nephrologist about the use of the buttonhole technique to cannulate the flixene vascular grafts.The button hole technique is a way to cannulate a graft using a dull needle placed into the exact same hole in the fistula every dialysis treatment instead of a sharp pointed needle every time.The instructions for use and within the flixene av access graft cannulation education pocket guide state: (be sure to rotate cannulation sites.Avoid sticking the graft in the same location twice to reduce the risk of graft damage and possible pseudoaneurysm formation).It is an expectation that the insertion of a needle into the body will result some level of pain.Individual physician practice determines how that pain will be treated or prevented.Atrium does not dictate physician practice, but provides instructions for use of the device.Based on the review of the product complaint details atrium medical corporation cannot confirm nor conclude that the manufacture or design of the product is at fault.There is ample information in the literature indicating that cannulating in the same location with the flixene grafts is not recommended.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FLIXENE VASCULAR GRAFTS
Type of Device
PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER
Manufacturer (Section D)
ATRIUM MEDICAL CORPORATION
40 continental blvd
merrimack NH 03054
MDR Report Key10170152
MDR Text Key195718144
Report Number3011175548-2020-00827
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 06/18/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Initial Date Manufacturer Received 06/08/2020
Initial Date FDA Received06/18/2020
Supplement Dates Manufacturer Received10/14/2020
Supplement Dates FDA Received10/27/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-